George Sellers
Stock Analyst at Stephens & Co.
(1.28)
# 3,278
Out of 4,829 analysts
43
Total ratings
24.24%
Success rate
-8.59%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Reiterates: Overweight | $68 | $34.77 | +95.57% | 7 | Aug 7, 2024 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $129.73 | +123.54% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $43.64 | +32.91% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $115.00 | +54.78% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $12.07 | +98.80% | 6 | May 29, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $36.65 | +96.45% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $1.12 | +346.43% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $7.36 | +239.90% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $20.40 | +179.41% | 6 | Aug 14, 2023 | |
| GKOS Glaukos | Reiterates: Overweight | $71 | $94.39 | -24.78% | 4 | May 8, 2023 |
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $34.77
Upside: +95.57%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $129.73
Upside: +123.54%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $43.64
Upside: +32.91%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $115.00
Upside: +54.78%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $12.07
Upside: +98.80%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $36.65
Upside: +96.45%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $1.12
Upside: +346.43%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $7.36
Upside: +239.90%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $20.40
Upside: +179.41%
Glaukos
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $94.39
Upside: -24.78%